Zenith Drugs Quarterly Results for Trading Insights
ZENITHDRUG • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹10 Cr
QMarch 2024
Zenith Drugs Quarterly Results Key Highlights
- Revenue of ₹134 Cr in March 2024 (+0.0% vs March 2024, +15.5% vs March 2023)
- Net Profit of ₹10 Cr in March 2024 (+0.0% vs March 2024, +100.0% vs March 2023)
- EBITDA of ₹19 Cr in March 2024 (+0.0% vs March 2024)
- Operating Margin of 13.0% in March 2024 (+0.0pp vs March 2024)
- Earnings Per Share of ₹5.63 in March 2024 (+0.0% vs March 2024)
Zenith Drugs Quarterly Results Analysis
| Metric | 2026 | March 2024 | March 2023 | March 2022 | QoQ | YoY |
|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 134 | 116 | 93 | - | - |
| Net Profit (₹ Cr) | 0 | 10 | 5 | 3 | - | - |
| EBITDA (₹ Cr) | 0 | 19 | 10 | 8 | - | - |
| EPS (₹) | 0.00 | 5.63 | 122.02 | 78.22 | - | - |
| Operating Margin (%) | 0.0% | 13.0% | 8.0% | 7.0% | - | - |
Zenith Drugs Share Price Trend Around Quarterly Results
Visualize Zenith Drugs's 1-year price movement across quarterly results — ideal for logging trades in Zenith Drugs share price
chart using Tickjournal. All values in ₹.
Related Pages for Zenith Drugs
Additional stock information and data for ZENITHDRUG
Revenue Trend (₹ Cr)
March 2022
93
March 2023
116
March 2024
134
2026
0
Net Profit Trend (₹ Cr)
March 2022
3
March 2023
5
March 2024
10
2026
0
Operating Margin Trend (%)
March 2022
7.0%
March 2023
8.0%
March 2024
13.0%
2026
0.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Zenith Drugs quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores